No association between hypertension and risk for Alzheimer's disease: A meta-analysis of longitudinal studies

Journal of Alzheimer's Disease

Volumn 27, Issue 4, 2011, Pages 799-807

  Guan, Jun Wen ^a,d   Huang, Chang Quan ^b,c   Li, Yong Hong ^e   Wan, Chao Min ^b   You, Chao ^a   Wang, Zheng Rong ^a   Liu, Yan You ^b   Liu, Qing Xiu ^c  

^a SICHUAN UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c Third Hospital of Mianyang   (China)

^d Department of Cardiology   (China)

^e CHENGDU UNIVERSITY OF INFORMATION TECHNOLOGY   (China)

Author keywords

Alzheimer's disease; hypertension; meta analysis

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AGED; ALZHEIMER DISEASE; ARTICLE; DISEASE ASSOCIATION; EMBASE; HUMAN; HYPERTENSION; INCIDENCE; LONGITUDINAL STUDY; MALE; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; RISK FACTOR;

EID: 84455173803     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2011-111160     Document Type: Article

References (38)

1. Elliott P (2000) High blood pressure in the community. In: Handbook of Hypertension, Epidemiology of Hypertension, Bulpitt CJ, ed. Elsevier Scientific B.V., Amsterdam 20, 1-18
2. Launer L, Masaki K, Petrovitch H, Foley D, Havlik R (1995) The association between midlife blood pressure levels and late-life cognitive function. JAMA 274, 1846-1851 (Pubitemid 26001260)
3. Skoog I, Lernfelt B, Landahl S (1996) A 15 year longitudinal study of blood pressure and dementia. Lancet 347, 1141-1145 (Pubitemid 126512042)
4. Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4, 487-499 (Pubitemid 40982459)
5. Birns J, Morris R, Donaldson N, Kalra L (2006) The effects of blood pressure reduction on cognitive function: A review of effects based on pooled data from clinical trials. J Hypertens 24, 1907-1914 (Pubitemid 44371252)
6. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, Abbott R, Godwin J, Dyer A, Stamler J (1990) Blood pressure, stroke, and coronary heart disease: Part 1-prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 335, 765-774 (Pubitemid 20106689)
7. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K (2005) Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 25, 277-281
8. Ziegler-Graham K, Brookmeyer R, Johnson E, Arrighi HM (2008) Worldwide variation in the doubling time of Alzheimers disease incidence rates. Alzheimers Dement 4, 316-323
9. Stampfer MJ (2006) Cardiovascular disease and Alzheimers disease: Common links. J Int Med 260, 211-223 (Pubitemid 44253634)
10. Stewart R, Xue Ql, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ (2009) Change in blood pressure and incident dementia:A32-year prospective study. Hypertension 54, 233-240
11. Qiu C, von Strauss E, Fastbom J, Winblad B, Fratiglioni L (2003) Low blood pressure and risk of dementia in the Kungsholmen project: A 6-year follow-up study. Arch Neurol 60, 223-228 (Pubitemid 36193966)
12. Treiber KA, Lyketsos CG, Corcoran C, Steinberg M, Norton M, Green RC, Rabins P, Stein DM, Welsh-Bohmer KA, Breitner JC, Tschanz JT (2008) Vascular factors and risk for neuropsychiatric symptoms in Alzheimers disease: The Cache County Study. Int Psychogeriatr 20, 538-553 (Pubitemid 351465551)
13. Tyas SL, Manfreda J, Strain LA, Montgomery PR (2001) Risk factors for Alzheimers disease: A population-based, longitudinal study in Manitoba, Canada. Int J Epidemiol 30, 590-597 (Pubitemid 32600256)
14. Luchsinger JA, Reitz C, Honig LS, Tang MX, Shea S, Mayeux R (2005) Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology 65, 545-551 (Pubitemid 41170713)
15. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, McDowell I (2002) Risk factors for Alzheimers disease: A prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 156, 445-453 (Pubitemid 34976983)
16. Muller M, Tang MX, Schupf N, Manly JJ, Mayeux R, Luchsinger JA (2007) Metabolic syndrome and dementia risk in a multiethnic elderly cohort. Dement Geriatr Cogn Disord 24, 185-192 (Pubitemid 47312668)
17. Becker JT, ChangYF, Lopez OL, DewMA,Sweet RA, Barnes D, Yaffe K, Young J, Kuller L (2009) Reynolds CF 3rd. Depressed mood is not a risk factor for incident dementia in a community-based cohort. Am J Geriatr Psychiatry 17, 653-663
18. Hassing LB, Dahl AK, Thorvaldsson V (2009) Overweight in midlife and risk of dementia: A 40-year follow-up study. Int J Obes (Lond) 33, 893-898
19. Peters R, Beckett N, Forette F, Tuomilehto J, ClarkeR, Ritchie C, Waldman A, Walton I, Poulter R, Ma S, Comsa M, Burch L, Fletcher A, Bulpitt C (2008) for the HYVET investigators. Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): A double-blind, placebo controlled trial. Lancet Neurol 7, 683-689
20. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhäger WH, Babarskiene MR, Babeanu S, Bossini A, Gil-Extremera B, Girerd X, Laks T, Lilov E, Moisseyev V, Tuomilehto J, Vanhanen H, Webster J, Yodfat Y, Fagard R (1998) on behalf of the Syst-Eur Investigators. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 352, 1347-1351 (Pubitemid 28510916)
21. Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM (2001) Antihypertensive drugs and incidence of dementia: the Rotterdam Study. Neurobiol Aging 22, 407-412 (Pubitemid 32510912)
22. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P (2006) Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol 5, 64-74 (Pubitemid 41790697)
23. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D (2000) Meta-analysis of Observational Studies in Epidemiology (MOOSE): a proposal for reporting. JAMA 283, 2008-2012 (Pubitemid 30214957)
24. Razay G, Vreugdenhil A, Wilcock G (2007) The metabolic syndrome and Alzheimer disease. Arch Neurol 64, 93-96 (Pubitemid 46072429)
25. Haag MD, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH (2009) Duration of antihypertensive drug use and risk of dementia: A prospective cohort study. Neurology 72, 1727-1734
26. Purnell C, Gao S, Callahan CM, Hendrie HC (2009) Cardiovascular risk factors and incident Alzheimer disease: a systematic review of the literature. Alzheimer Dis Assoc Disord 23, 1-10
27. Luchsinger JA, Mayeux R (2004) Cardiovascular risk factors and Alzheimers disease. Curr Atheroscler Rep 6, 261-266 (Pubitemid 39359464)
28. Kivipelto M, Ngandu T, Laatikainen T, Winblad B, Soininen H, Tuomilehto J (2006) Risk score for the prediction of dementia risk in 20 years among middle aged people: A longitudinal, population based study. Lancet Neurol 5, 735-741 (Pubitemid 44205512)
29. Kelley BJ, Petersen RC (2007) Alzheimers disease and mild cognitive impairment. Neurol Clin 25, 577-609 (Pubitemid 47058874)
30. Iadecola C (2004) Neurovascular regulation in the normal brain and in Alzheimers disease. Nat Rev Neurosci 5, 347-360 (Pubitemid 38568496)
31. Skoog I, Gustafson D (2006) Update on hypertension and Alzheimers disease. Neurol Res 28, 605-611
32. Sheng B, Cheng LF, Law CB, Li HL, Yeung KM, Lau KK (2007) Coexisting cerebral infarction in Alzheimers disease is associated with fast dementia progression: applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et lEnseignement en Neurosciences Neuroimaging Criteria in Alzheimers Disease with Concomitant Cerebral Infarction. J Am Geriatr Soc 55, 918-922 (Pubitemid 47011031)
33. Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813-817 (Pubitemid 27111317)
34. McDowell I (2001) Alzheimers disease: insights from epidemiology. Aging (Milano) 13, 143-162
35. Iadecola C, Davisson RL (2008) Hypertension and cerebrovascular dysfunction. Cell Metab 7, 476-484 (Pubitemid 351729202)
36. Vasilevko V, Passos GF, Quiring D, Head E, Kim RC, Fisher M, CribbsDH(2010) Aging and cerebrovascular dysfunction: contribution of hypertension, cerebral amyloid angiopathy, and immunotherapy. Ann N Y Acad Sci 1207, 58-70
37. Yamaguchi H, Maki Y, Maki Y (2010) Tube feeding can be discontinued by taking dopamine agonists and angiotensinconverting enzyme inhibitors in the advanced stages of dementia. J Am Geriatr Soc 58, 2035-2036
38. Purandare N, Oude Voshaar RC, Davidson Y, Gibbons L, Hardicre J, Byrne J, McCollum C, Jackson A, Burns A, Mann DM (2006) Deletion/insertion polymorphism of the angiotensin-converting enzyme gene and white matter hyperintensities in dementia: A pilot study. J Am Geriatr Soc 54, 1395-1400 (Pubitemid 44342890)